Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer

Akira Nakamura, Kenichi Akiyama, Toshiyuki Takai

研究成果: Review article査読

16 被引用数 (Scopus)

抄録

Immune activation and inhibitory receptors play an important role in the maitenance of an adequate activation threshold of various cells in our immune system. Analyses of murine models show that the inhibitory Fc receptor, FcγRIIB plays an indispensable role in the suppression of antibody-mediated allergy and autoimmunity. In contrast, the activating-type Fc receptors (FcRs) are essential for the development of these diseases, suggesting that regulation of inhibitory or activating FcR is an ideal target as a therapeutic agent. In addition, recent crystal structural analyses of FcR-Ig-Fc fragment complexes provide an effective approach for developing FcR-targeting drugs. This review summarises recent advances of FcR, which were mainly obtained by murine studies, and highlights novel antibodies as possible FcR-targeting therapies for allergy, autoimmune diseases and cancer.

本文言語English
ページ(範囲)169-190
ページ数22
ジャーナルExpert Opinion on Therapeutic Targets
9
1
DOI
出版ステータスPublished - 2005 2 1

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

フィンガープリント 「Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル